Fin Trust Capital Advisors, LLC Vanda Pharmaceuticals Inc. Transaction History

Fin Trust Capital Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 20, 2022	SELL	$9.44 - $11.76 $4,701 - $5,856	-498 Reduced 80.19%	123 $1,000
Q1 2022 May 03, 2022	SELL	$10.84 - $16.55 $1.13 Million - $1.73 Million	-104,268 Reduced 99.41%	621 $7,000
Q4 2021 Feb 14, 2022	SELL	$15.69 - $21.14 $17,149 - $23,106	-1,093 Reduced 1.03%	104,889 $1.65 Million
Q3 2021 Nov 16, 2021	BUY	$15.35 - $21.27 $66,542 - $92,205	4,335 Added 4.26%	105,982 $1.82 Million
Q2 2021 Aug 16, 2021	BUY	$15.71 - $21.51 $1.6 Million - $2.19 Million	101,647 New	101,647 $2.19 Million
Q1 2019 May 09, 2019	SELL	$17.59 - $31.05 $17,590 - $31,050	-1,000 Closed	0 $0
Q4 2018 Feb 11, 2019	BUY	$18.97 - $31.47 $18,970 - $31,470	1,000 New	1,000 $26,000

161

45.2M

165K

33.6K

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $264M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

Get notified when there are updates to the investment portfolio of Fin Trust Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Fin Trust Capital Advisors, LLC with notifications on news.